Adenovirus (Ad) as Vaccine-vectors - Creative Biolabs
Frontiers | B-Cell Immunophenotyping to Predict Vaccination Outcome in the Immunocompromised - A Systematic Review
Insertion of a selectable marker by recombineering.(a) Targeting... | Download Scientific Diagram
Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–April 10, 2021 | MMWR
Covid-19 Breakthrough Infections in Vaccinated Health Care Workers | NEJM
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development | ACS Central Science
MYCOBACTERIUM COMPRISING EXPRESSION VECTOR WITH TWO AUXOTROPHIC SELECTION MARKERS AND ITS USE AS VACCINE - diagram, schematic, and image 12
Biomaterials at the interface of nano- and micro-scale vector–cellular interactions in genetic vaccine design - Journal of Materials Chemistry B (RSC Publishing) DOI:10.1039/C4TB01058B
Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study -
Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine | PNAS
Sucrose selection with RNA-OUT selection marker encoding Nature... | Download Scientific Diagram
Live attenuated vaccines, a favorable strategy to provide long-term immunity against protozoan diseases: Trends in Parasitology
A Selectable and Excisable Marker System for the Rapid Creation of Recombinant Poxviruses | PLOS ONE
Genetic components of a plasmid DNA vaccine. The essential components... | Download Scientific Diagram
Pre-Clinical Development of BCG.HIVACAT, an Antibiotic-Free Selection Strain, for HIV-TB Pediatric Vaccine Vectored by Lysine Auxotroph of BCG | PLOS ONE
Ensuring safety of DNA vaccines | Microbial Cell Factories | Full Text
Frontiers | SARS-CoV-2 Variants, Vaccines, and Host Immunity
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12–18 Years — United States, July–December 2021 | MMWR
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes | Science
MYCOBACTERIUM COMPRISING EXPRESSION VECTOR WITH TWO AUXOTROPHIC SELECTION MARKERS AND ITS USE AS VACCINE - diagram, schematic, and image 13
Vaccine vial monitor (VVM)
RNA selectable marker DNA vaccine plasmids. Purple arrow in bacterial... | Download Scientific Diagram
Landscape and selection of vaccine epitopes in SARS-CoV-2 | Genome Medicine | Full Text
